Oncology & Cancer

Cancer and HIV—closing the screening gap

While collaborating with clinical colleagues in rural southwest Georgia, Emory cancer researcher Theresa Gillespie learned a surprising fact. The region has one of the state's largest HIV/AIDS populations outside of metropolitan ...

Oncology & Cancer

Specialists make breakthrough in the treatment of anal cancer

Specialists at The Christie and The University of Manchester have made a breakthrough which could potentially improve detection and treatment of anal cancer, as well as have wider implications for other cancers.

Oncology & Cancer

Genetic test for anal cancer could identify those at high risk

A new test, based on a patient's epigenetics, could be an accurate and inexpensive way to find and treat those at highest risk of anal cancer - a disease with growing incidence in women, men who have sex with men (MSM) and ...

Oncology & Cancer

Anal cancer rates rising in many parts of the world

(HealthDay)—Anal cancer rates are on the rise in many countries. But vaccination against human papillomavirus (HPV)—a virus linked to the development of anal cancer—may help curb rates of the disease, a new study suggests.

Diseases, Conditions, Syndromes

HPV-vaccinated women protect men from infection

A Melbourne study has found the first evidence of 'herd protection' from vaccinations against the cervical cancer-causing human papillomavirus (HPV).

Oncology & Cancer

HPV16 seropositivity relatively common before anal cancer

(HealthDay)—Human papillomavirus (HPV) type 16 (HPV16) seropositivity is relatively common before anal cancer diagnosis, according to a study published online Feb. 9 in the Journal of Clinical Oncology.

page 2 from 4